Post Categories
QPS will have a strong presence at ASCPT 2016 in San Diego March 9th-11th
March 9, 2016
QPS will have a strong presence at ASCPT 2016 in San Diego March 9th-11th. Several members of QPS’ Early Phase Clinical team will be…
QPS is proud to announce that our toxicology facility passed a GLP audit by the US FDA in 3Q 2015 with no major findings.
March 7, 2016
We are exhibiting at SOT 55th Annual Meeting and ToxExpoTM. Please visit our booth (#1813) between March 13-16 at the New Orleans Convention Center,…
QPS Global Clinical Operations Team Aces Enrollment for Global Study of Prostate Cancer Drug and Completes the First Patient in Europe!
March 2, 2016
QPS has been assisting an international Sponsor to perform a global, late-phase study to investigate the safety, efficacy, and pharmacokinetic behavior of a newly…
QPS will create an (LC)-ICP-MS assay to perform the critical elemental analysis in your drug development study
March 1, 2016
If you need to quantify blood zinc levels, are working on a gadolinium-based MRI contrast agent, or need to measure platinum levels in mouse…
QPS Seen As Inspirational for Delaware
February 25, 2016
Where do you turn when you just took the package? 25% of DuPont employees (likely more on the way) got the bad news here…
Consultation open on revised EMA Guideline on Medicines to treat Alzheimer’s Disease
February 15, 2016
The European Medicines Agency (EMA) has released a draft guideline revision on the clinical investigation of medicines for the treatment of Alzheimer’s disease and…
New ICP-MS Magnesium (Mg) Assays in Human Plasma and Urine added to the QPS Global Assay Database
February 9, 2016
The role of Mg in human nutrition has recently received renewed interest. Mg dietary intake has been reported to have decreased during the last…
See QPS in London at Informa’s Early Clinical Development Conference, 23 – 24 February 2016
February 5, 2016
On February 23, Professor Zuzana Diamant, MD PhD, Director of Respiratory & Allergy Research at QPS, will talk about Biomarkers in Respiratory Drug Development…
Read the QPS Whitepaper on Phase I Site Selection to support EU Registration
January 6, 2016
Making the right decision about where to conduct Phase I of a clinical trial is crucial. As long as basic EU regulatory requirements are…
Wishing You a Very Happy New Year, With Some Very Cool Science
December 16, 2015
Cancer immuno therapies. Oligo therapeutics. CAR T-cell therapies. Breakthrough Antivirals. For the past 20 years, we’ve been following the path of solid science and…
Just Out! QPS Scientist LingSing Chen Contributes Biosimilars Expertise to eBook
November 16, 2015
LingSing Chen, PhD, former VP and Global Head of Translational Medicine and Biosimilars at QPS, shares her bioanalytical expertise in a new eBook published…
Growth and Goals-Our Next 10 Years: QPS 20th Anniversary Series, Part 6
October 28, 2015
The past 20 years for QPS have included countless hours of hard work, exciting change and a tireless commitment to do what is right…
How Ancient Wolves Evolved into Man’s Best Friend
August 29, 2022
If you compare a pack of fearsome ancient wolves with a pack of modern-day chihuahuas, it’s clear that domesticated dogs have evolved almost beyond…
Could Bear Serum Help the Bedridden?
August 22, 2022
Prolonged periods of rest are essential for the sick and those recovering from surgery, but bed rest takes its toll on human bodies. Animal…
Study Finds Norovirus Could Spread Through Saliva
August 17, 2022
Norovirus is the most common cause of acute gastroenteritis, causing an estimated 685 million cases each year. The virus can lead to severe illness…
Hangry Is Officially a Thing. So, What Should We Do About It?
August 8, 2022
In 2018 the word “hangry,” the portmanteau of hungry and angry, was finally added to the Oxford English Dictionary. We say finally because the…
Are Fully Hypoallergenic Cats the Pets of the Future?
August 3, 2022
Pet owners represent a whopping 70 percent of U.S. households, with dogs and cats reigning supreme as the most popular pets. But while cat…
The Japan Model: Limiting the Impact of COVID Without Lockdowns
August 1, 2022
Japan, a country with a population, on average, 10 years older than that of the United States of America, experienced a comparably minimal impact…
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…
TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…
